Tocagen, Inc. (TOCA)


Stock Price Forecast

June 15, 2020


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Tocagen, Inc. chart...

About the Company

Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer. It is in the business of discovery, development, and commercialization of products for the treatment of cancer. The company was founded by Thomas E. Darcy, Harry E. Gruber, Douglas J. Jolly, and Dennis N. Berman in August 2007 and is headquartered San Diego, CA.

Sector

Health Technology

Industry

Biotechnology

Employees

29

CEO

Martin J. Duvall

Exchange

NASDAQ

Website

http://www.tocagen.com

$0M

Total Revenue

29

Employees

$3M

Market Capitalization

-0.04

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $TOCA News

Buy Recommendation for Forte Biosciences on Strong Potential of Novel FB-102 Treatment and Market Position

15d ago, source:

In a report released today, Michael Higgins from Ladenburg Thalmann & Co. upgraded Forte Biosciences (FBRX – Research Report) to a ...

Forte Biosciences Inc (FBRX)

27d ago, source: Investing

Forte Biosciences, Inc.(FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced key R&D updates for FB-102 and the closing of financing to support the ...

Inc. 5000 Conference

4y ago, source: Inc

She spoke at the 2023 Inc. 5000 Conference about the difference between marketing and advertising. At the Inc. 5000 Conference, Howroyd, the first Black woman to build and own a billion-dollar ...

About Inc.com | Everything You Need to Know to Grow and Start Your Business

12y ago, source: Inc

Inc. is the voice of the American entrepreneur. We inspire, inform, and document the most fascinating people in business: the risk-takers, the innovators, and the ultra-driven go-getters that ...

Snap Inc.

2mon ago, source: Wall Street Journal

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Avaya Inc

3y ago, source: Forbes

Avaya provides solutions to enhance and simplify communications and collaboration, including unified communications and contact center solutions. The company focuses on cloud communications and a ...

Apple Inc.

3y ago, source: Wall Street Journal

1 Day AAPL -1.22% DJIA 0.56% S&P 500 -0.88% Technology -5.78% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum ...

MPW Medical Properties Trust, Inc.

3d ago, source: Seeking Alpha

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama ...

Macy's, Inc. (M)

3d ago, source: Yahoo Finance

Vanguard Small Cap Value Index Fund 4.81M Dec 31, 2023 1.75% 89,121,520 Vanguard Extended Market Index Fund 4.05M Dec 31, 2023 1.47% 75,050,783 Avantis U.S. Small Cap Value Fund 3.32M Dec 31, 2023 ...

T-Mobile US Inc.

3y ago, source: MarketWatch

Rogers Communications Inc. Cl A-1.68% $28.32B Rogers Communications Inc. Cl B 0.45% $28.32B ...

Nike Inc. Cl B

2y ago, source: MarketWatch

Under Armour Inc. Cl C 1.73% $2.87B Under Armour Inc. Cl A 1.82% $2.87B ...

Ennis, Inc. (EBF) Stock Price, News, Quote & History - Yahoo Finance

3y ago, source: Yahoo Finance

MIDLOTHIAN, Texas, March 25, 2024--Keith S. Walters, Chairman, President and Chief Executive Officer of Ennis, Inc. (NYSE: EBF), a manufacturer of business forms and other business products ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...